Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2017 Publisher: Breath Limited, Whiddon Valley, Barnstaple, North Devon, EX32 8NS, United Kingdom
Budesonide 0.5mg Nebuliser Suspension.
| Pharmaceutical Form |
|---|
|
Nebuliser suspension. White to off-white suspension. |
One ml of suspension contains 0.25mg budesonide.
One ampoule of 2ml suspension contains 0.5mg budesonide.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Budesonide |
Budesonide is a glucocorticosteroid with a high local anti-inflammatory effect. At doses clinically equivalent to systemically acting glucocorticosteroids, budesonide gives significantly less HPA axis suppression and has a lower impact on inflammatory markers. |
| List of Excipients |
|---|
|
Disodium edetate |
Low density polyethylene ampoule containing 2ml nebuliser suspension.
Pack sizes: Tri-laminate foil sachets containing 5, 20, 24, 40 (2 × 20) and 60 ampoules (in strips of 4, 5, 8, 10 or 12 ampoules).
Not all pack sizes may be marketed.
Breath Limited, Whiddon Valley, Barnstaple, North Devon, EX32 8NS, United Kingdom
PL: 18023/0007
26-10-2005 / 24-02-2009
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
